Vascepa (Icosapent ethyl)

News
Article

New molecular entity: FDA approved icosapent ethyl (Vascepa, Amarin Pharmaceuticals Ireland Limited), an ethyl ester of eicosapentaenoic acid (EPA), as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.